| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13111* | 2021 |
| Mechanisms of hepatic fibrogenesis SL Friedman Gastroenterology 134 (6), 1655-1669, 2008 | 3377 | 2008 |
| Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver SL Friedman Physiological reviews 88 (1), 125-172, 2008 | 3301 | 2008 |
| Mechanisms of NAFLD development and therapeutic strategies SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal Nature medicine 24 (7), 908-922, 2018 | 3025 | 2018 |
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury SL Friedman Journal of Biological Chemistry 275 (4), 2247-2250, 2000 | 3022 | 2000 |
| Liver fibrosis–from bench to bedside SL Friedman Journal of hepatology 38, 38-53, 2003 | 2573 | 2003 |
| Mechanisms of hepatic stellate cell activation T Tsuchida, SL Friedman Nature reviews Gastroenterology & hepatology 14 (7), 397-411, 2017 | 2265 | 2017 |
| Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis E Vilar-Gomez, Y Martinez-Perez, L Calzadilla-Bertot, A Torres-Gonzalez, ... Gastroenterology 149 (2), 367-378. e5, 2015 | 2101 | 2015 |
| Pathogenesis of liver fibrosis V Hernandez-Gea, SL Friedman Annual review of pathology: mechanisms of disease 6, 425-456, 2011 | 2004 | 2011 |
| The cellular basis of hepatic fibrosis--mechanisms and treatment strategies SL Friedman New England Journal of Medicine 328 (25), 1828-1835, 1993 | 1858 | 1993 |
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ... New England Journal of Medicine 359 (19), 1995-2004, 2008 | 1329 | 2008 |
| Mechanisms of hepatic fibrogenesis UE Lee, SL Friedman Best practice & research Clinical gastroenterology 25 (2), 195-206, 2011 | 1195 | 2011 |
| Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Y Hoshida, SMB Nijman, M Kobayashi, JA Chan, JP Brunet, DY Chiang, ... Cancer research 69 (18), 7385-7392, 2009 | 1177 | 2009 |
| p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs M Müller, S Wilder, D Bannasch, D Israeli, K Lehlbach, M Li-Weber, ... The Journal of experimental medicine 188 (11), 2033-2045, 1998 | 1154 | 1998 |
| Hepatic stellate cells as key target in liver fibrosis T Higashi, SL Friedman, Y Hoshida Advanced drug delivery reviews 121, 27-42, 2017 | 1130 | 2017 |
| Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis L Xu, AY Hui, E Albanis, MJ Arthur, SM O’byrne, WS Blaner, P Mukherjee, ... Gut 54 (1), 142-151, 2005 | 1099 | 2005 |
| Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. SL Friedman, FJ Roll, J Boyles, DM Bissell Proceedings of the National Academy of Sciences 82 (24), 8681-8685, 1985 | 1074 | 1985 |
| Liver cancer cell of origin, molecular class, and effects on patient prognosis D Sia, A Villanueva, SL Friedman, JM Llovet Gastroenterology 152 (4), 745-761, 2017 | 1068 | 2017 |
| Pathobiology of liver fibrosis: a translational success story YA Lee, MC Wallace, SL Friedman Gut 64 (5), 830-841, 2015 | 942 | 2015 |
| Mechanisms and disease consequences of nonalcoholic fatty liver disease R Loomba, SL Friedman, GI Shulman Cell 184 (10), 2537-2564, 2021 | 909 | 2021 |
